ECONOMIC EVALUATION OF RITUXIMAB VERSUS AZATHIOPRINE FOR MAINTENANCE TREATMENT OF ANCA-ASSOCIATED VASCULITIS: THE MAINRITSAN TRIAL

被引：0
|
作者：
Montante, Annalisa [1 ]
Le Bras, Alicia [1 ]
Terrier, Benjamin [1 ]
Cohen, Pascal [1 ]
Puechal, Xavier [1 ]
Karras, Alexandre [1 ]
Ravaud, Philippe [1 ]
Guillevin, Loic [1 ]
Durand-Zaleski, Isabelle [1 ]
机构：
[1] French Vasculitis Study Grp, Paris, France
来源：
RHEUMATOLOGY | 2017年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
WS7_3
引用
收藏
页码：32 / 33
页数：2
相关论文
共 50 条
  • [41] Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis.
    Jones, Rachel B.
    Tervaert, Jan Willem Cohen
    Hauser, Thomas
    Luqmani, Raashid
    Morgan, Matthew D.
    Peh, Chen Au
    Savage, Caroline O.
    Segelmark, Marten
    Tesar, Vladimir
    van Paassen, Pieter
    Walsh, Dorothy
    Walsh, Michael
    Westman, Kerstin
    Jayne, David R. W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03): : 211 - 220
  • [42] Rituximab in ANCA-associated vasculitis: a revolution?
    Tervaert, Jan Willem Cohen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (10) : 3077 - 3079
  • [43] Rituximab to treat ANCA-associated vasculitis
    Guillevin, L.
    Mahr, A.
    REVUE DE MEDECINE INTERNE, 2011, 32 (10): : 591 - 593
  • [44] MAINTENANCE TREATMENT OF ANCA-ASSOCIATED VASCULITIS BEYOND 18 MONTHS OF RITUXIMAB: A PILOT EXPERIENCE
    Bartoletti, A.
    Milanesi, A.
    Monti, S.
    Montecucco, C.
    Delvino, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [45] RITAZAREM: AN INTERNATIONAL, OPEN-LABEL, RANDOMISED CONTROLLED TRIAL COMPARING RITUXIMAB WITH AZATHIOPRINE AS MAINTENANCE THERAPY IN RELAPSING ANCA-ASSOCIATED VASCULITIS
    Smith, Rona Marie
    Arimura, Yoshihiro
    Merkel, Peter A.
    Jayne, David R. W.
    RHEUMATOLOGY, 2017, 56 : 150 - 151
  • [46] Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines
    Tieu, Joanna
    Smith, Rona
    Basu, Neil
    Brogan, Paul
    D'Cruz, David
    Dhaun, Neeraj
    Flossmann, Oliver
    Harper, Lorraine
    Jones, Rachel B.
    Lanyon, Peter C.
    Luqmani, Raashid A.
    McAdoo, Stephen P.
    Mukhtyar, Chetan
    Pearce, Fiona A.
    Pusey, Charles D.
    Robson, Joanna C.
    Salama, Alan D.
    Smyth, Lucy
    Watts, Richard A.
    Willcocks, Lisa C.
    Jayne, David R. W.
    RHEUMATOLOGY, 2020, 59 (04) : e24 - e32
  • [47] Successful treatment of ANCA-associated vasculitis and CNS involvement with rituximab
    Zeglam, S.
    Werthmann, M.
    Scheicht, D.
    Bansmann, P.
    Strunk, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 145 - 145
  • [48] Induction treatment of ANCA-associated vasculitis with a single dose of rituximab
    Turner-Stokes, Tabitha
    Sandhu, Eleanor
    Pepper, Ruth J.
    Stolagiewicz, Natalie E.
    Ashley, Caroline
    Dinneen, Deirdre
    Howie, Alexander J.
    Salama, Alan D.
    Burns, Aine
    Little, Mark A.
    RHEUMATOLOGY, 2014, 53 (08) : 1395 - 1403
  • [49] LONG-TERM MAINTENANCE TREATMENT WITH RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS: A RETROSPECTIVE COHORT STUDY
    Chalkia, Aglaia
    Thomas, Konstantinos
    Kourniotis, Dimitrios
    Panagiotopoulos, Alexandros
    Alexakou, Zoe
    Mpora, Margarita
    Aggelis, George
    Vasilopoulos, Dimitrios
    Petras, Dimitrios
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [50] Rituximab or Cyclophosphamide in ANCA-Associated Renal Vasculitis
    Nossent, Johannes C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (21): : 2072 - 2072
12345